Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Dow
Fuji
Queensland Health
Fish and Richardson
UBS
Express Scripts
AstraZeneca
Healthtrust

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017684

« Back to Dashboard

NDA 017684 describes PYROLITE, which is a drug marketed by Pharmalucence and is included in one NDA. Additional details are available on the PYROLITE profile page.

The generic ingredient in PYROLITE is technetium tc-99m pyro/trimeta phosphates kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m pyro/trimeta phosphates kit profile page.
Summary for 017684
Tradename:PYROLITE
Applicant:Pharmalucence
Ingredient:technetium tc-99m pyro/trimeta phosphates kit
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Merck
Citi
Queensland Health
Boehringer Ingelheim
Deloitte
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.